Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,323 | 1 | 59.2% |
| Food and Beverage | $1,463 | 57 | 37.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110.00 | 1 | 2.8% |
| Education | $12.95 | 1 | 0.3% |
| Travel and Lodging | $12.84 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,398 | 3 | $0 (2017) |
| Astellas Pharma US Inc | $328.47 | 16 | $0 (2021) |
| AbbVie Inc. | $327.40 | 21 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $123.89 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $123.06 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $113.69 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $110.00 | 1 | $0 (2017) |
| Amgen Inc. | $93.17 | 1 | $0 (2019) |
| Boston Scientific Corporation | $69.38 | 4 | $0 (2023) |
| Avadel Specialty Pharmaceuticals, LLC | $60.85 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $70.86 | 4 | Myriad Genetic Laboratories, Inc. ($23.27) |
| 2022 | $59.48 | 3 | Boston Scientific Corporation ($22.15) |
| 2021 | $150.76 | 5 | Astellas Pharma US Inc ($80.46) |
| 2020 | $12.95 | 1 | Coloplast Corp ($12.95) |
| 2019 | $262.93 | 5 | Janssen Biotech, Inc. ($113.69) |
| 2018 | $504.65 | 22 | Astellas Pharma US Inc ($158.07) |
| 2017 | $2,860 | 21 | GENZYME CORPORATION ($2,398) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Urology Gynecology | ||||||
| 06/06/2023 | Curium US LLC | — | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| 03/09/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: rezum_URO | ||||||
| 02/14/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2022 | Boston Scientific Corporation | General - BPH (Device) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: General - BPH_URO | ||||||
| 03/15/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 01/11/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Prostate Cancer | ||||||
| 11/13/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $80.46 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2021 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/07/2021 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/23/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/16/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/14/2020 | Coloplast Corp | CONTINENCE CARE (Device) | Education | Cash or cash equivalent | $12.95 | General |
| Category: CONTINENCE | ||||||
| 06/05/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $93.17 | General |
| Category: Bone Health | ||||||
| 05/16/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $113.69 | General |
| Category: Oncology | ||||||
| 05/08/2019 | Analogic Corporation | — | Food and Beverage | Cash or cash equivalent | $26.55 | General |
| 04/25/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Endocrinology | ||||||
| 11/14/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Urology | ||||||
| 11/02/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $83.67 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: UROLOGY | ||||||
| 09/27/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,413 | 1,892 | $388,123 | $104,815 |
| 2022 | 21 | 1,504 | 2,138 | $434,918 | $119,264 |
| 2021 | 24 | 1,660 | 2,296 | $482,592 | $133,153 |
| 2020 | 30 | 2,074 | 6,515 | $774,677 | $242,542 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 272 | $63,920 | $25,061 | 39.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 144 | $136,800 | $19,458 | 14.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 40 | 52 | $29,900 | $9,828 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 144 | $23,040 | $8,976 | 39.0% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 20 | 28 | $25,480 | $7,338 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 53 | $16,642 | $6,665 | 40.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 19 | 20 | $20,360 | $5,674 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,558 | $3,412 | 35.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 36 | 36 | $12,204 | $3,053 | 25.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 132 | 147 | $7,644 | $3,004 | 39.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 198 | 247 | $10,127 | $1,947 | 19.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 43 | 46 | $4,600 | $1,919 | 41.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 17 | $6,562 | $1,849 | 28.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 23 | $3,680 | $1,600 | 43.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 79 | 79 | $1,580 | $1,453 | 92.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 36 | 36 | $6,228 | $1,347 | 21.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 251 | 363 | $3,630 | $796.40 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 116 | $696.00 | $682.08 | 98.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 24 | $2,232 | $648.48 | 29.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 18 | 18 | $3,240 | $104.76 | 3.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 20 | 183 | $173,850 | $26,539 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 250 | $58,750 | $23,630 | 40.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 48 | 67 | $38,525 | $13,299 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 184 | $29,440 | $11,655 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 63 | $19,782 | $8,846 | 44.7% |
About Dr. Howard Korman, MD
Dr. Howard Korman, MD is a Urology healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467433599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Korman, MD has received a total of $3,922 in payments from pharmaceutical and medical device companies, with $70.86 received in 2023. These payments were reported across 61 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($2,323).
As a Medicare-enrolled provider, Korman has provided services to 6,651 Medicare beneficiaries, totaling 12,841 services with total Medicare billing of $599,775. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties General Practice, Surgery
- Location Royal Oak, MI
- Active Since 11/07/2005
- Last Updated 06/25/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1467433599
Products in Payments
- JEVTANA (Drug) $2,508
- Lupron (Drug) $289.06
- XTANDI (Drug) $268.05
- INVOKANA (Drug) $123.89
- DARZALEX (Biological) $123.06
- Erleada (Drug) $113.69
- Prolia (Biological) $93.17
- Noctiva (Drug) $60.85
- Xtandi (Drug) $60.42
- LUPRON DEPOT (Drug) $38.34
- SPACEOAR VUE (Device) $31.96
- XIAFLEX (Biological) $23.84
- PROLARIS (Device) $23.27
- General - BPH (Device) $22.15
- ELIGARD (Drug) $20.00
- Prolaris (Device) $17.33
- Olympus Laser Devices (Device) $17.31
- Rezum Generator (Device) $15.27
- iTIND System (Device) $13.47
- CONTINENCE CARE (Device) $12.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Royal Oak
Richard Bennett, Md, MD
Urology — Payments: $607,905
Dr. Kenneth Peters, Md, MD
Urology — Payments: $26,596
Adam Gadzinski, M.d, M.D
Urology — Payments: $18,520
Dr. Jason Gilleran, Md, MD
Urology — Payments: $14,239
Melissa Fischer, Md, MD
Urology — Payments: $11,402
Dr. Hamza Beano, M.d, M.D
Urology — Payments: $8,264